TP53 and cancer: Furthermore, HCT116 cells (human colon carcinoma cells expressing a WT p53) were sensitized to mitomycin C upon p53 activation [26], and p53 activation improved platinum-based anti-cancer chemotherapy in a preclinical model [34].